Phillips JM, Ehrlichman RS, Siegel SJ. Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. Neuroscience. 2007 Feb 23;144(4):1314-23. Epub 2006 Dec 19.

Hans ML, Maxwell C, Ehrlichman RS, Metzger K, Liang Y, Siegel SJ, Lowman AM. Evaluation of in vitro release and in vivo efficacy of mPEG-PLA-haloperidol conjugate micelle-like structures. J Biomed Mater Res B Appl Biomater. 2007 Apr 5; [Epub ahead of print]

Metzger KL, Shoemaker JM, Kahn JB, Maxwell CR, Liang Y, Tokarczyk J, Kanes SJ, Hans M, Lowman AM, Dan N, Winey KI, Swerdlow NR, Siegel SJ. Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits. Psychopharmacology (Berl). 2007 Feb;190(2):201-11. Epub 2006 Nov 21.

Maxwell CR, Liang Y, Kelly MP, Kanes SJ, Abel T, Siegel SJ. Mice expressing constitutively active Gsalpha exhibit stimulus encoding deficits similar to those observed in schizophrenia patients. Neuroscience. 2006 Sep 1;141(3):1257-64. Epub 2006 Jun 5.

Metzger KL, Maxwell CR, Liang Y, Siegel SJ. Effects of nicotine vary across two auditory evoked potentials in the mouse. Biol Psychiatry. 2007 Jan 1;61(1):23-30. Epub 2006 Feb 21.

Maxwell CR, Ehrlichman RS, Liang Y, Trief D, Kanes SJ, Karp J, Siegel SJ. Ketamine produces lasting disruptions in encoding of sensory stimuli. J Pharmacol Exp Ther. 2006 Jan;316(1):315-24. Epub 2005 Sep 28.

Maxwell CR, Ehrlichman RS, Liang Y, Gettes DR, Evans DL, Kanes SJ, Abel T, Karp J, Siegel SJ. Corticosterone modulates auditory gating in mouse. Neuropsychopharmacology. 2006 May;31(5):897-903.

Siegel SJ, Maxwell CR, Majumdar S, Trief DF, Lerman C, Gur RE, Kanes SJ, Liang Y. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials. Neuroscience. 2005;133(3):729-38.

Frankel WN, Beyer B, Maxwell CR, Pretel S, Letts VA, Siegel SJ. Development of a new genetic model for absence epilepsy: spike-wave seizures in C3H/He and backcross mice. J Neurosci. 2005 Mar 30;25(13):3452-8.

Maxwell CR, Kanes SJ, Abel T, Siegel SJ. Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications. Neuroscience. 2004;129(1):101-7.

Connolly PM, Maxwell C, Liang Y, Kahn JB, Kanes SJ, Abel T, Gur RE, Turetsky BI, Siegel SJ. The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components. Neurochem Res. 2004 Jun;29(6):1179-88.

Maxwell CR, Liang Y, Weightman BD, Kanes SJ, Abel T, Gur RE, Turetsky BI, Bilker WB, Lenox RH, Siegel SJ (2004) Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential. Neuropsychopharmacology 29: 739-46

Siegel, S. J., Ginsberg, S. D., Hof, P. R., Foote, S. L., Young, W. G., Kraemer, G. W., McKinney, W. T. and Morrison, J. H. Effects of Social Deprivation in Prepubescent Rhesus Monkeys: Immunohistochemical Analysis of the Neurofilament Protein Triplet in the Hippocampal Formation. Brain Res. 619 (1993) 299-305.

Siegel, S. J., Brose, N., Janssen, W. G., Gasic, G. P., Jahn, R., Heinemann, S. F. and Morrison, J. H. Regional, cellular, and ultrastructural distribution of the glutamate receptor subunit NMDAR1 in monkey hippocampus. [Full Text PDF]. Proc. Natl. Acad. Sci. USA 91 (1994) 564-568.

Siegel, S. J., Janssen, W. G., Tullai, J. W., Rogers, S. W., Moran, T., Heinemann, S. F. and Morrison, J. H. Distribution of the Excitatory Amino Acid Receptor Subunits GluR2 (4) in Monkey Hippocampus and Colocalization with Subunits GluR5-7 and NMDAR1. J. Neurosci. 15 (1995) 2707-2719.

Gazzaley, A.H., Siegel, S.J., Kordower, J.H., Mufson, E.J. and Morrison, J.H. Circuit-specific alterations of N-methyl-D-aspartate receptor subunit 1 in the dentate gyrus of aged monkeys. [Full Text PDF]. Proc. Natl. Acad. Sci. USA 93 (1996) 3121-3125.

Gur, R.C., Ragland, J.D., Moberg, P.J., Turner, T.H., Bilker, W.B., Kohler, C., Siegel, S. J., and Gur R. E. Computerized Neurocognitive Scanning: I.Methodology and validation in healthy people. Neuropsychopharmacology, 25, (2001) 766-776.

Gur, R. C., Ragland, J. D., Moberg, P. J., Bilker, W. B., Kohler, C., Siegel, S. J., and Gur R. E. Computerized Neurocognitive Scanning II: The Profile of Schizophrenia. Neuropsychopharmacology, 25, (2001) 777-788.

Siegel, S. J., Winey, K., Gur, R. E., Lenox, R. H., Ikeda, D., Gandhi, N., and Zhang, W., Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia. Neuropsychopharmacology, 26, (2002) 817-23.

Siegel S.J., Connolly P., Liang Y., Lenox R.H., Gur R.E., Bilker W.B., Kanes S.J., Turetsky B.I., The effects of strain, novelty and NMDA blockade on auditory evoked potentials in mice. Neuropsychopharmacology, 2003. 28(4): p. 675-82.

Bilker, W.B., Brensinger, C., Kurtz, M., Kohler, C., Gur, R.C., Siegel , S.J., and Gur, R.E., Development of an Abbreviated Schizophrenia Quality of Life Scale Using a New Method. Neuropsychopharmacology, 28, (2003) , 773-777.

Ragland, J.D., Moelter, S. T., McGrath, C., Hill, S. K., Gur, R.E., Bilker, W.B., Siegel, S.J. and Gur, R.C., Levels-Of-Processing Effect on Word Recognition in Schizophrenia, Biol Psychiatry, 2003. 54(11): p. 1154-61.

Kohler CG, Turner TH, Bilker WB, Brensinger CM, Siegel SJ, Kanes SJ, Gur RE, Gur RC (2003) Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am J Psychiatry 160: 1768-74

Connolly PM, Maxwell CR, Kanes SJ, Abel T, Liang Y, Tokarczyk J, Bilker WB, Turetsky BI, Gur RE, Siegel SJ (2003) Inhibition of auditory evoked potentials and prepulse inhibition of startle in DBA/2J and DBA/2Hsd inbred mouse substrains. Brain Res 992: 85-95

Gur RE, Kohler C, Ragland JD, Siegel SJ, Bilker WB, Loughead J, Phend N, Gur RC (2003) Neurocognitive performance and clinical changes in olanzapine-treated patients with schizophrenia. Neuropsychopharmacology 28: 2029-36

Moberg PJ, Arnold SE, Doty RL, Kohler C, Kanes S, Siegel S, Gur RE, Turetsky BI (2003) Impairment of odor hedonics in men with schizophrenia. Am J Psychiatry 160: 1784-9

Gelber, E.I., Kohler, C.G., Bilker, W.B., Brensinger, C., Siegel, S.J., Kanes, S.J. and Gur, R.E., Symptom and Demographic Profiles in First-Episode Schizophrenia, Res, 2004. 67(2-3): p. 185-94.

Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, Hahn CG, Siegel SJ, Trojanowski JQ, Gur RE, Blake DJ, Arnold SE (2004) Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 113: 1353-63

Irani F, Dankert M, Brensinger C, Bilker WB, Nair SR, Kohler CG, Kanes SJ, Turetsky BI, Moberg PJ, Ragland JD, Gur RC, Gur RE, Siegel SJ (2004) Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology 29: 960-8

Gur RE, Kohler C, Turetsky BI, Siegel SJ, Kanes SJ, Bilker WB, Brennan AR, Gur RC (2004) A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biol Psychiatry 55: 512-7

Gould, T.J., Bizily, S.P., Tokarczyk, J., Kelly, M.P., Siegel, S.J, Kanes, S.J., and Abel, T., (2004) Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha, Neuropsychopharmacology 29 (3) 494-501

Ragland, J.D., Lowrey, N., Indersmitten, T., Kohler, C.G., Kanes, S.J., Siegel, S.J., Gur, R.E., and Gur, R.C., (2004) Relationship Between Semantic Fluency and Verbal Learning in Schizophrenia: Role of Controlled Versus Automatic Processing, American Journal of Psychiatry, 161 (6), 1004-1115

Ragland, J.D., Gur, R.C., Valdez, J.N., Loughead, J., Elliott, M., Kohler, C., Kanes, S., Siegel, S.J., Moelter, S.T., Gur, R.E.: Levels-of-processing effect on frontotemporal function in schizophrenia during word encoding and recognition. American Journal of Psychiatry, in press.

Siegel, S.J., Irani, F., Brensinger, C.M., Kohler, C.G., Bilker, W.B., Ragland, J.D., Kanes, S. J., Gur, R.C., Gur, R.E., Prognostic variables at intake and long-term level of function in schizophrenia, American Journal of Psychiatry, in press.

Hans, M., Shimoni, K., Danino, D., Siegel, S.J. and Lowman, A., Synthesis and characterization of mpeg-pla prodrug micelles, Biomacromolecules, in press

Budhian, A, Siegel, SJ, Winey, KI, Production of haloperidol loaded PLGA nanoparticles for extended controlled drug release of haloperidol, in press

Editorials, Reviews and Chapters:

Hans, M.L, Dan, L., Winey, K.I., Lowman, A.M., Siegel, S.J., Daily to Annual Biodegradable Drug Delivery Strategies for Psychoactive Compounds: Handbook of Biodegradable Polymeric Materials & Applications, Edited by S.K. Mallapragada, American Scientific Publishers, Stevenson Ranch, CA (2004)

Siegel, S. J., Increased patient autonomy through long-term antipsychotic delivery systems in schizophrenia. Exert Rev. Neurotherapeutics 2(6) (2002) 89-91

Morrison, J.H, Siegel, S.J., Gazzaley, A.H., and Huntley, G.W. Glutamate receptors: Emerging links between subunit proteins and specific excitatory circuits in primate hippocampus and neocortex. The Neuroscientist, 2 (1996) 272-283.

Irani, F., Dankert, M. and Siegel, S.J., Patient and family attitudes towards schizophrenia treatment, Current Psychiatry Reports, 6 (4) (2004) 283-8

Siegel, S.J., Extended Release Drug Delivery Strategies in Psychiatry: Theory to Practice, Psychiatry 2005, 2:6 22-31